CVS Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Current	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar '26 Mar 23, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021
Market Cap	90,696	100,867	95,745	87,398	85,501	56,561	79,103	74,179	99,860	101,700	89,858	88,625	95,042	121,147	125,412	121,570	132,180	136,378	112,100	109,974
Market Cap Growth	6.08%	78.33%	21.04%	17.82%	-14.38%	-44.38%	-11.97%	-16.30%	5.07%	-16.05%	-28.35%	-27.10%	-28.10%	-11.17%	11.88%	10.54%	33.82%	52.42%	46.64%	29.51%
Enterprise Value	160,048	164,582	160,457	148,055	147,921	123,283	145,467	136,278	163,108	165,292	150,066	151,042	150,541	174,678	173,773	175,198	190,997	194,307	174,857	177,973
Last Close Price	71.29	79.36	75.39	68.98	67.75	44.89	62.88	59.06	79.76	78.96	69.82	69.13	74.31	93.19	95.37	92.66	101.21	103.16	84.86	83.44
PE Ratio	51.29	57.09	198.39	19.27	16.17	12.27	15.96	10.51	14.02	12.20	10.50	29.93	23.82	28.59	38.93	14.85	16.73	17.14	14.81	15.28
Forward PE	9.95	11.54	11.39	11.24	11.48	7.77	9.21	8.06	9.61	9.39	8.12	8.04	8.42	10.67	11.01	11.03	12.22	12.88	11.11	10.77
PEG Ratio	0.88	0.76	0.66	0.75	0.49	0.61	2.47	2.01	1.83	1.92	1.58	1.37	1.18	2.05	1.71	1.88	1.89	2.15	1.66	1.47
PS Ratio	0.23	0.25	0.24	0.23	0.23	0.15	0.21	0.20	0.28	0.28	0.26	0.26	0.29	0.38	0.40	0.39	0.44	0.47	0.39	0.40
PB Ratio	1.20	1.34	1.31	1.13	1.11	0.75	1.06	0.99	1.35	1.33	1.21	1.22	1.33	1.70	1.77	1.62	1.79	1.82	1.51	1.50
P/TBV Ratio	1.21	1.35	1.31	1.13	1.11	0.75	1.06	0.99	1.37	1.34	1.21	1.22	1.34	1.72	1.77	1.63	1.82	1.84	1.52	1.51
P/FCF Ratio	11.62	12.92	15.21	18.28	14.39	8.94	46.89	14.07	12.27	9.78	7.95	5.01	5.46	9.01	6.43	7.66	8.16	8.66	7.38	9.47
P/OCF Ratio	8.52	9.48	10.51	11.55	9.76	6.21	17.16	9.19	9.17	7.57	6.37	4.32	4.74	7.49	5.67	6.56	6.98	7.47	6.29	7.76
EV/Sales Ratio	0.40	0.41	0.41	0.38	0.39	0.33	0.39	0.38	0.45	0.46	0.43	0.45	0.45	0.54	0.55	0.57	0.64	0.67	0.61	0.64
EV/EBITDA Ratio	10.94	17.76	16.85	13.15	12.41	9.40	10.31	8.64	9.55	9.13	8.22	15.85	15.27	14.34	22.60	11.94	13.33	10.92	11.10	10.44
EV/EBIT Ratio	15.97	35.32	32.64	16.53	15.38	14.48	15.28	11.01	12.98	12.03	10.73	23.68	19.27	21.96	26.17	12.86	14.38	14.60	12.96	13.01
EV/FCF Ratio	20.50	21.08	25.50	30.97	24.90	19.49	86.23	25.84	20.04	15.90	13.28	8.55	8.66	12.99	8.91	11.04	11.79	12.34	11.51	15.32
Debt / Equity Ratio	0.98	0.98	1.04	0.96	0.97	1.02	1.01	1.04	1.03	0.98	1.02	1.08	1.02	0.96	0.96	0.90	0.94	0.93	1.01	1.06
Debt / EBITDA Ratio	8.63	24.53	-25.49	34.74	17.94	23.59	99.40	27.53	23.99	17.61	16.63	18.93	17.20	15.03	-18.14	15.89	16.52	32.40	25.70	18.41
Debt / FCF Ratio	10.24	30.68	834.20	64.13	21.30	75.93	-58.45	34.20	19.48	-22.38	36.89	15.45	11.85	-26.53	8.32	14.73	30.22	22.30	16.01	14.86
Net Debt / Equity Ratio	0.92	0.92	0.97	0.89	0.89	0.95	0.97	0.90	0.93	0.89	0.86	0.90	0.82	0.76	0.72	0.79	0.88	0.85	0.89	0.95
Net Debt / EBITDA Ratio	7.49	21.28	-21.99	28.79	15.14	20.46	87.77	22.19	20.15	15.07	13.27	15.04	13.21	11.65	-13.03	12.68	14.06	27.06	21.50	16.07
Net Debt / FCF Ratio	8.88	26.61	719.59	53.14	17.98	65.87	-51.61	27.56	16.37	-19.15	29.44	12.27	9.10	-20.58	5.98	11.75	25.71	18.63	13.40	12.97
Asset Turnover	0.42	0.42	0.41	0.39	0.37	0.39	0.38	0.36	0.36	0.39	0.37	0.37	0.36	0.36	0.35	0.35	0.33	0.33	0.32	0.31
Inventory Turnover	18.56	4.93	4.87	5.09	4.75	4.69	4.66	4.67	4.38	4.31	4.23	4.35	3.95	3.80	3.82	3.89	3.55	3.47	3.50	3.55
Quick Ratio	0.57	0.57	0.59	0.58	0.59	0.56	0.54	0.60	0.54	0.59	0.60	0.59	0.61	0.62	0.64	0.62	0.54	0.55	0.59	0.58
Current Ratio	0.84	0.84	0.83	0.80	0.82	0.81	0.80	0.86	0.81	0.86	0.86	0.86	0.92	0.95	0.94	0.91	0.88	0.88	0.94	0.95
Return on Equity (ROE)	3.87%	3.87%	-5.38%	1.33%	2.36%	2.13%	0.09%	2.39%	1.54%	2.76%	3.11%	2.58%	2.94%	3.17%	-4.67%	4.08%	3.24%	1.91%	2.21%	3.93%
Return on Assets (ROA)	1.80%	1.80%	-1.45%	0.57%	0.91%	0.72%	0.22%	0.92%	0.66%	1.07%	1.15%	1.00%	1.09%	1.16%	-1.29%	1.49%	1.20%	0.83%	0.97%	1.39%
Return on Invested Capital (ROIC)	2.78%	2.78%	-2.24%	0.90%	1.40%	1.09%	0.34%	1.41%	1.01%	1.62%	1.77%	1.50%	1.60%	1.71%	-1.90%	2.11%	1.66%	1.15%	1.34%	1.91%
Return on Capital Employed (ROCE)	1.27%	1.27%	-1.94%	1.42%	2.03%	1.40%	0.49%	1.78%	1.37%	2.05%	2.25%	1.94%	2.11%	2.23%	-2.38%	2.80%	2.13%	1.41%	1.80%	2.52%
Earnings Yield	1.95%	1.75%	0.50%	5.19%	6.18%	8.15%	6.27%	9.52%	7.13%	8.19%	9.52%	3.34%	4.20%	3.50%	2.57%	6.73%	5.98%	5.84%	6.75%	6.54%
FCF Yield	8.61%	7.74%	6.57%	5.47%	6.95%	11.18%	2.13%	7.11%	8.15%	10.22%	12.58%	19.94%	18.30%	11.10%	15.55%	13.05%	12.25%	11.55%	13.55%	10.56%
Dividend Yield	3.73%	0.84%	0.88%	0.99%	0.98%	1.48%	1.06%	1.16%	0.84%	0.77%	0.87%	0.90%	0.82%	0.59%	0.58%	0.61%	0.54%	0.48%	0.59%	0.59%
Payout Ratio	191.37%	28.71%	-21.28%	84.82%	47.22%	50.97%	962.07%	48.47%	75.47%	38.07%	34.45%	41.82%	36.47%	30.81%	-21.32%	24.43%	30.67%	47.24%	41.24%	23.36%
Buyback Yield / Dilution	-0.23%	-0.23%	-0.19%	-0.22%	-0.17%	5.03%	3.58%	3.81%	2.82%	1.88%	3.83%	4.68%	5.53%	2.74%	2.77%	2.28%	1.21%	-0.28%	-0.25%	-0.23%
Total Shareholder Return	3.50%	0.60%	0.70%	0.77%	0.82%	6.52%	4.64%	4.96%	3.65%	2.65%	4.69%	5.58%	6.35%	3.33%	3.35%	2.89%	1.75%	0.20%	0.34%	0.36%

Updated Feb 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q